To treat metastatic cancer, a radiotherapeutic must deliver a potent isotope to the tumor and keep it there long enough to kill the cancer, but clear quickly enough to avoid harming healthy tissue. So far, few radiotherapeutics have managed to meet both requirements.   Boston-based Asta Bio aims to overcome these challenges with 211-Astatine—the most druggable […]

The $10 billion precision agriculture industry is struggling to power the millions of sensors it needs to improve crop yields, reduce costs, and support food security amidst climate change. Farms are usually remote and lacking in energy infrastructure, but sensors reliant on single-use batteries or solar systems are prohibitively expensive because they require maintenance. Someone […]

The global transition to net-zero emissions hinges on the mining of critical minerals, yet copper and lithium production, projected to grow 30% and 465% by 2050, will still fall short of meeting demand. Mining faces daunting challenges: 70% of copper remains locked in low-grade ores, and extracting it is increasingly uneconomical due to the massive […]

HexemBio is pioneering the world’s first blood stem cell rejuvenation therapy, a breakthrough platform emerging from >15 Millions from NIH. The company has raised $7.5 million in Seed funding and recently held a successful FDA Pre-IND meeting in January 2026 after being granted Orphan Drug Designation. Its technology, published in Nature, has been featured in […]

The $5 trillion bioeconomy aims to produce next-generation food, fuels, and fabrics, but it faces a critical bottleneck: a shortage of affordable, carbon-negative feedstocks. Global demand for sugars and cellulose will soon outstrip supply, threatening cost and scalability challenges for industries like precision fermentation, bioplastics, upcycled textiles, and green building materials. Meanwhile, 2 billion tons […]

The world depends on insulation that wastes up to 60% of heating and cooling energy, is heavy and bulky, and is 80% derived from petrochemicals. There’s been little innovation in this $65 billion industry, which still sells thick glass, sand, and plastic composites invented nearly a century ago. Aerogels—the lightest, thinnest, and best insulating materials […]

The varroa mite is the leading cause of bee colony collapse. The current solutions aren’t good enough, or the problem wouldn’t exist. In the U.S., at least 45% of commercial colonies are infected with varroa; between 2023 and 2024, 55.1% died off. Unless we want food shortages and price spikes, the world needs a biopesticide […]

The world’s $6.2 trillion in crop production depends on domesticated plants that have been optimized for yield, not resilience. Their defensive mechanisms against pests have been silenced, and in their stead, chemical pesticides have protected crops, ending hunger in much of the world. In a changing climate, however, pests are spreading and evolving quicker than […]

Medical researchers have genetically modified T cells to recognize and attack cancers, but they’ve run into some obstacles. Chimeric antigen receptor T (CAR-T) therapies are expensive ($373-475K per treatment), ineffective against solid tumors, potentially neurotoxic, and require gene editing if they’re sourced from healthy donors. That severely limits their potential for commercialization.  Tinkeso Therapeutics is […]